Quick Answer
Bath & Body Works, Inc. reported Cash and Equivalents of $953.00 million for fiscal year 2026.
Bath & Body Works, Inc. Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2026 | $953.00M | +41.4% |
| 2025 | $674.00M | -37.8% |
| 2024 | $1.08B | -12.0% |
| 2023 | $1.23B | -37.7% |
| 2022 | $1.98B | -44.5% |
| 2021 | $3.57B | +138.0% |
| 2020 | $1.50B | +6.1% |
| 2019 | $1.41B | -6.7% |
| 2018 | $1.51B | -21.7% |
| 2017 | $1.93B | -24.1% |
| 2016 | $2.55B | +51.6% |
| 2015 | $1.68B | +0.0% |
| 2014 | $1.68B | +117.5% |
| 2013 | $773.00M | -17.3% |
| 2012 | $935.00M | -17.3% |
| 2011 | $1.13B | -37.4% |
| 2010 | $1.80B | +53.8% |
| 2009 | $1.17B | +15.2% |
| 2008 | $1.02B | +103.6% |
| 2007 | $500.00M | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| October 31, 2025 | $236.00M | +23.6% | -35.2% |
| July 31, 2025 | $364.00M | -29.2% | -42.8% |
| April 30, 2025 | $636.00M | -25.6% | -5.6% |
| January 31, 2025 | $674.00M | -37.8% | +252.9% |
| October 31, 2024 | $191.00M | -53.6% | -62.8% |
| July 31, 2024 | $514.00M | -34.9% | -39.9% |
| April 30, 2024 | $855.00M | -18.3% | -21.1% |
| January 31, 2024 | $1.08B | -12.0% | +163.1% |
- Bath & Body Works, Inc. showed an increase of +41.4% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2007–2026 period, Bath & Body Works, Inc.’s cash and equivalents has grown by 90.6% (from $500.00 million to $953.00 million).
- The most recent figure is from Bath & Body Works, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 12, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: